Detalles de la búsqueda
1.
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis.
Antimicrob Agents Chemother
; 68(5): e0158423, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526046
2.
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31611349
3.
In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters.
Antimicrob Agents Chemother
; 59(4): 2426-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25605350
4.
Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.
Antimicrob Agents Chemother
; 58(8): 4911-4, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24841272
5.
In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Antimicrob Agents Chemother
; 56(9): 4608-13, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22687509
6.
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
J Antimicrob Chemother
; 72(2): 622-624, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27856721
7.
In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.
J Antimicrob Chemother
; 66(4): 840-4, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21393192
8.
Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.
J Antimicrob Chemother
; 65(7): 1441-7, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20435780
9.
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Antimicrob Agents Chemother
; 53(8): 3552-60, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19506065
10.
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Antimicrob Agents Chemother
; 53(11): 4762-71, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19738026
11.
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Antimicrob Agents Chemother
; 52(12): 4388-99, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779357
12.
In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest.
J Clin Microbiol
; 46(9): 2862-7, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18596149
13.
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
J Antimicrob Chemother
; 61(3): 595-602, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18218646
14.
Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs.
Diagn Microbiol Infect Dis
; 60(2): 221-4, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17976944
15.
Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution.
Diagn Microbiol Infect Dis
; 92(3): 250-252, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042035
16.
In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
Diagn Microbiol Infect Dis
; 89(3): 205-211, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28826987
17.
Evaluation of the bactericidal activity of Telavancin against Staphylococcus aureus using revised testing guidelines.
Diagn Microbiol Infect Dis
; 89(1): 83-85, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28669676
18.
Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Diagn Microbiol Infect Dis
; 87(2): 121-128, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27890418
19.
Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents.
PLoS One
; 8(12): e84409, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24386374
20.
Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010.
Diagn Microbiol Infect Dis
; 73(3): 267-70, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22579652